Aim: Evaluate the clinical benefit of external beam radiotherapy (RTx) for locally invasive
thyroid carcinoma with follicular cell differentiation (DTC). Patients, methods: The Multicentre …

The initial management of thyroid cancer is usually surgery, followed by radioactive iodine in
differentiated thyroid cancer. The role of external beam radiotherapy for gross residual or …

PURPOSE: To evaluate the efficacy of external beam radiation therapy (EBRT) for
differentiated thyroid carcinomas. METHODS: Forty-two patients with a locally advanced or …

External beam radiotherapy (EBRT) is not a first line treatment in differentiated thyroid
carcinoma (DTC), but is recommended as an adjuvant treatment in certain cases. The …

Objective We evaluated the efficacy and safety of postoperative radiotherapy (PORT) for
differentiated thyroid cancer (DTC) with high risk features. Materials and Methods This …

The clinical features, management and outcome of 1348 patients diagnosed with
differentiated thyroid carcinoma in Queen Elizabeth Hospital, Hong Kong, were analysed …

PURPOSE: Thyroid carcinoma is the second most common malignancy in young women,
after breast cancer, aged 15–34 years in Hong Kong. Radioiodine or 131I (RAI) has been …

Background Whether to sacrifice or spare the recurrent laryngeal nerve (RLN) when
papillary thyroid carcinoma (PTC) involves a functioning RLN remains controversial …

Iodine-131 or radioactive iodine benefits patients with differentiated thyroid carcinoma by
treating recurrences and in reducing relapses after operation. Postoperative ablation of …

Papillary thyroid carcinoma is the most common thyroid malignancy, and has an excellent
prognosis, even with cervical lymph node metastasis; however, histological variants are …